Form 4: Sabra Health Care REIT Director, Catherine Cusack, Receives Stock Grant

Sentiment:

SEC Form 4 Filing


Catherine Cusack, a director at Sabra Health Care REIT, Inc., was granted 9,480 shares of common stock on June 13, 2024, under the company's 2009 Performance Incentive Plan.

Summary

  • On June 13, 2024, Catherine Cusack, a director of Sabra Health Care REIT, Inc., received a grant of 9,480 shares of common stock.
  • The grant was made under the Issuer's 2009 Performance Incentive Plan.
  • These restricted stock units vest in equal monthly installments starting July 13, 2024, and ending on the earlier of June 13, 2025, or the day before the next annual stockholders' meeting.
  • Following the transaction, Cusack beneficially owns 56,573 shares of common stock, which includes 9,480 unvested stock units and 35,093 stock units that have vested but the payment of which has been deferred.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction (stock grant) that is generally viewed positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

  • The grant of restricted stock units aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages continued service and contribution to the company.

Future Outlook

The director's stock units will vest monthly until June 13, 2025, or the day before the next annual stockholders' meeting, incentivizing continued service.

Industry Context

Stock grants to directors are a common practice in REITs and other publicly traded companies to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

  • Stock grants to directors are a common practice across the REIT industry.
  • Companies like Welltower (WELL) and Ventas (VTR) also utilize stock grants as part of their director compensation packages.
  • The vesting schedules and amounts of these grants are typically benchmarked against peer companies to ensure competitiveness.

Stakeholder Impact

  • The stock grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term performance.
  • Employees may view the stock grant as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
06/13/2024Date of the transaction: Grant of restricted stock units.
07/13/2024Start date for monthly vesting of restricted stock units.
06/13/2025End date for monthly vesting of restricted stock units (or earlier, depending on the date of the next annual stockholders' meeting).
06/17/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.